$CELU
Celularity Inc. Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCelularity Inc. Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is CELU down today? It is at $1.27 (-1.55%), and our scanner flagged it 142 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CELU spikes, and full due diligence on CELU — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CELU 142 times in the last 30 days. Create a free account to track $CELU, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CELU from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CELU today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Brigido Stephen Officer | Sold (automatic/other) | -268 | sold 2.8% | 9K | $343 at $1.28 | Apr 13, 26 |
Brigido Stephen Officer | Other | 821 | added 9.2% | 10K | n/a | Apr 13, 26 |
Hariri Robert J Officer | Sold (automatic/other) | -1K | sold <0.1% | 2.85M | $2K at $1.28 | Apr 13, 26 |
Hariri Robert J Officer | Other | 3K 0.01% of company | added 0.1% | 2.85M | n/a | Apr 13, 26 |
Haines John R Officer | Sold (automatic/other) | -583 | sold 1.9% | 30K | $746 at $1.28 | Apr 13, 26 |
Haines John R Officer | Other | 2K | added 5.6% | 31K | n/a | Apr 13, 26 |
Diamandis Peter Director | Acquired (grant/award) | +20K 0.07% of company | added 5.5% | 394K | n/a | Jan 12, 26 |
Parks Diane L. Director | Acquired (grant/award) | +30K 0.1% of company | added 6.1% | 520K | n/a | Jan 12, 26 |
Levien Vincent Director | Acquired (grant/award) | +29K 0.10% of company | added 23% | 154K | n/a | Jan 12, 26 |
Ling Geoffrey M.D. Director | Acquired (grant/award) | +19K 0.07% of company | added 8.1% | 256K | n/a | Jan 12, 26 |
Diamandis Peter Director | Acquired (grant/award) | +125K 0.4% of company | added 50% | 374K | n/a | Dec 29, 25 |
Parks Diane L. Director | Acquired (grant/award) | +125K 0.4% of company | added 34% | 490K | n/a | Dec 29, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on CELU from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CELU today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CELU last traded at $1.27, down 1.55% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The CELU Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CELU 142 times in the last 30 days.
CELU (Celularity Inc. Class A Common Stock) trades on XNAS, with a market cap of about $37M in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CELU for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CELU discussion
Sign in to ask a question or join the discussion.